請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/31296
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 陳俊任(Chun-Jen Chen) | |
dc.contributor.author | Chia-chi Lu | en |
dc.contributor.author | 陸家祺 | zh_TW |
dc.date.accessioned | 2021-06-13T02:41:16Z | - |
dc.date.available | 2016-09-08 | |
dc.date.copyright | 2011-09-08 | |
dc.date.issued | 2011 | |
dc.date.submitted | 2011-08-01 | |
dc.identifier.citation | 1. Barton GM: A calculated response: control of inflammation by the innate immune system. J Clin Invest 2008, 118(2):413-420.
2. Serhan CN, Savill J: Resolution of inflammation: the beginning programs the end. Nat Immunol 2005, 6(12):1191-1197. 3. Kono H, Rock KL: How dying cells alert the immune system to danger. Nat Rev Immunol 2008, 8(4):279-289. 4. Seely AJ, Pascual JL, Christou NV: Science review: Cell membrane expression (connectivity) regulates neutrophil delivery, function and clearance. Crit Care 2003, 7(4):291-307. 5. Bacon KB, Oppenheim JJ: Chemokines in disease models and pathogenesis. Cytokine Growth Factor Rev 1998, 9(2):167-173. 6. Sandler C, Lindstedt KA, Joutsiniemi S, Lappalainen J, Juutilainen T, Kolah J, Kovanen PT, Eklund KK: Selective activation of mast cells in rheumatoid synovial tissue results in production of TNF-alpha, IL-1beta and IL-1Ra. Inflammation research 2007, 56(6):230-239. 7. Chen G, Goeddel DV: TNF-R1 signaling: a beautiful pathway. Science 2002, 296(5573):1634-1635. 8. Zhou Z, Connell MC, MacEwan DJ: TNFR1-induced NF-kappaB, but not ERK, p38MAPK or JNK activation, mediates TNF-induced ICAM-1 and VCAM-1 expression on endothelial cells. Cell Signal 2007, 19(6):1238-1248. 9. Hacham M, Argov S, White RM, Segal S, Apte RN: Different patterns of interleukin-1alpha and interleukin-1beta expression in organs of normal young and old mice. Eur Cytokine Netw 2002, 13(1):55-65. 10. Ulich TR, Guo KZ, Irwin B, Remick DG, Davatelis GN: Endotoxin-induced cytokine gene expression in vivo. II. Regulation of tumor necrosis factor and interleukin-1 alpha/beta expression and suppression. Am J Pathol 1990, 137(5):1173-1185. 11. Mandinova A, Soldi R, Graziani I, Bagala C, Bellum S, Landriscina M, Tarantini F, Prudovsky I, Maciag T: S100A13 mediates the copper-dependent stress-induced release of IL-1 alpha from both human U937 and murine NIH 3T3 cells. J Cell Sci 2003, 116(13):2687-2696. 12. Dinarello CA: Biologic basis for interleukin-1 in disease. Blood 1996, 87(6):2095-2147. 13. Elkon KB: IL-1alpha responds to necrotic cell death. Nat Med 2007, 13(7):778-780. 14. Miller LS, Pietras EM, Uricchio L, O'Connell RM, Hirano KA, Rao S, Cheung AL, Cheng G, Modlin RL: IL-1 beta and the inflammasome but not IL-1 alpha mediate IL-1R-dependent neutrophil recruitment against Staphylococcus aureus skin infection. Journal of Investigative Dermatology 2007, 127:S130-S130. 15. Kamari Y, Werman-Venkert R, Shaish A, Werman A, Harari A, Gonen A, Voronov E, Grosskopf I, Sharabi Y, Grossman E et al: Differential role and tissue specificity of interleukin-1alpha gene expression in atherogenesis and lipid metabolism. Atherosclerosis 2007, 195(1):31-38. 16. Nakae S, Asano M, Horai R, Iwakura Y: Interleukin-1 beta, but not interleukin-1 alpha, is required for T-cell-dependent antibody production. Immunology 2001, 104(4):402-409. 17. Nathan C: Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol 2006, 6(3):173-182. 18. Ramaiah SK, Jaeschke H: Role of neutrophils in the pathogenesis of acute inflammatory liver injury. Toxicol Pathol 2007, 35(6):757-766. 19. Kitamura Y: Heterogeneity of mast cells and phenotypic change between subpopulations. Annu Rev Immunol 1989, 7:59-76. 20. Kawakami T, Galli SJ: Regulation of mast-cell and basophil function and survival by IgE. Nat Rev Immunol 2002, 2(10):773-786. 21. Chen CC, Grimbaldeston MA, Tsai M, Weissman IL, Galli SJ: Identification of mast cell progenitors in adult mice. Proc Natl Acad Sci U S A 2005, 102(32):11408-11413. 22. Miller HR, Wright SH, Knight PA, Thornton EM: A novel function for transforming growth factor-beta1: upregulation of the expression and the IgE-independent extracellular release of a mucosal mast cell granule-specific beta-chymase, mouse mast cell protease-1. Blood 1999, 93(10):3473-3486. 23. Galli SJ: New insights into 'the riddle of the mast cells': microenvironmental regulation of mast cell development and phenotypic heterogeneity. Lab Invest 1990, 62(1):5-33. 24. Metz M, Grimbaldeston MA, Nakae S, Piliponsky AM, Tsai M, Galli SJ: Mast cells in the promotion and limitation of chronic inflammation. Immunol Rev 2007, 217:304-328. 25. McDermott JR, Bartram RE, Knight PA, Miller HR, Garrod DR, Grencis RK: Mast cells disrupt epithelial barrier function during enteric nematode infection. Proc Natl Acad Sci U S A 2003, 100(13):7761-7766. 26. Theoharides TC, Alysandratos KD, Angelidou A, Delivanis DA, Sismanopoulos N, Zhang B, Asadi S, Vasiadi M, Weng Z, Miniati A et al: Mast cells and inflammation. Biochim Biophys Acta 2010. 27. Kubes P, Granger DN: Leukocyte-endothelial cell interactions evoked by mast cells. Cardiovasc Res 1996, 32(4):699-708. 28. Wang Y, Thorlacius H: Mast cell-derived tumour necrosis factor-alpha mediates macrophage inflammatory protein-2-induced recruitment of neutrophils in mice. Br J Pharmacol 2005, 145(8):1062-1068. 29. Vieira SM, Lemos HP, Grespan R, Napimoga MH, Dal-Secco D, Freitas A, Cunha TM, Verri WA, Jr., Souza-Junior DA, Jamur MC et al: A crucial role for TNF-alpha in mediating neutrophil influx induced by endogenously generated or exogenous chemokines, KC/CXCL1 and LIX/CXCL5. Br J Pharmacol 2009, 158(3):779-789. 30. Skokos D, Le Panse S, Villa I, Rousselle JC, Peronet R, David B, Namane A, Mecheri S: Mast cell-dependent B and T lymphocyte activation is mediated by the secretion of immunologically active exosomes. J Immunol 2001, 166(2):868-876. 31. McLachlan JB, Hart JP, Pizzo SV, Shelburne CP, Staats HF, Gunn MD, Abraham SN: Mast cell-derived tumor necrosis factor induces hypertrophy of draining lymph nodes during infection. Nat Immunol 2003, 4(12):1199-1205. 32. Yoshikawa T, Imada T, Nakakubo H, Nakamura N, Naito K: Rat mast cell protease-I enhances immunoglobulin E production by mouse B cells stimulated with interleukin-4. Immunology 2001, 104(3):333-340. 33. Galli SJ, Grimbaldeston M, Tsai M: Immunomodulatory mast cells: negative, as well as positive, regulators of immunity. Nat Rev Immunol 2008, 8(6):478-486. 34. West GB: Pharmacology of the tissue mast cell. Br J Dermatol 1958, 70(11):409-417. 35. Huynh ML, Fadok VA, Henson PM: Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation. J Clin Invest 2002, 109(1):41-50. 36. Lotze MT, Tracey KJ: High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol 2005, 5(4):331-342. 37. Scaffidi P, Misteli T, Bianchi ME: Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002, 418(6894):191-195. 38. Rovere-Querini P, Capobianco A, Scaffidi P, Valentinis B, Catalanotti F, Giazzon M, Dumitriu IE, Muller S, Iannacone M, Traversari C et al: HMGB1 is an endogenous immune adjuvant released by necrotic cells. EMBO Rep 2004, 5(8):825-830. 39. Binder RJ, Anderson KM, Basu S, Srivastava PK: Cutting edge: heat shock protein gp96 induces maturation and migration of CD11c+ cells in vivo. J Immunol 2000, 165(11):6029-6035. 40. Feng H, Zeng Y, Graner MW, Likhacheva A, Katsanis E: Exogenous stress proteins enhance the immunogenicity of apoptotic tumor cells and stimulate antitumor immunity. Blood 2003, 101(1):245-252. 41. Mathis D, Vence L, Benoist C: beta-Cell death during progression to diabetes. Nature 2001, 414(6865):792-798. 42. Damico FM, Kiss S, Young LH: Sympathetic ophthalmia. Semin Ophthalmol 2005, 20(3):191-197. 43. Dressler W: A post-myocardial infarction syndrome; preliminary report of a complication resembling idiopathic, recurrent, benign pericarditis. J Am Med Assoc 1956, 160(16):1379-1383. 44. Hu DE, Moore AM, Thomsen LL, Brindle KM: Uric acid promotes tumor immune rejection. Cancer Res 2004, 64(15):5059-5062. 45. Kokkola R, Andersson A, Mullins G, Ostberg T, Treutiger CJ, Arnold B, Nawroth P, Andersson U, Harris RA, Harris HE: RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages. Scand J Immunol 2005, 61(1):1-9. 46. Ishii KJ, Suzuki K, Coban C, Takeshita F, Itoh Y, Matoba H, Kohn LD, Klinman DM: Genomic DNA released by dying cells induces the maturation of APCs. J Immunol 2001, 167(5):2602-2607. 47. Decker P, Singh-Jasuja H, Haager S, Kotter I, Rammensee HG: Nucleosome, the main autoantigen in systemic lupus erythematosus, induces direct dendritic cell activation via a MyD88-independent pathway: consequences on inflammation. J Immunol 2005, 174(6):3326-3334. 48. Carp H: Mitochondrial N-formylmethionyl proteins as chemoattractants for neutrophils. J Exp Med 1982, 155(1):264-275. 49. Eigenbrod T, Park JH, Harder J, Iwakura Y, Nunez G: Cutting edge: critical role for mesothelial cells in necrosis-induced inflammation through the recognition of IL-1 alpha released from dying cells. J Immunol 2008, 181(12):8194-8198. 50. Moussion C, Ortega N, Girard JP: The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin'? PLoS One 2008, 3(10):e3331. 51. Li M, Carpio DF, Zheng Y, Bruzzo P, Singh V, Ouaaz F, Medzhitov RM, Beg AA: An essential role of the NF-kappa B/Toll-like receptor pathway in induction of inflammatory and tissue-repair gene expression by necrotic cells. J Immunol 2001, 166(12):7128-7135. 52. Chen CJ, Kono H, Golenbock D, Reed G, Akira S, Rock KL: Identification of a key pathway required for the sterile inflammatory response triggered by dying cells. Nat Med 2007, 13(7):851-856. 53. Iyer SS, Pulskens WP, Sadler JJ, Butter LM, Teske GJ, Ulland TK, Eisenbarth SC, Florquin S, Flavell RA, Leemans JC et al: Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome. Proc Natl Acad Sci U S A 2009, 106(48):20388-20393. 54. Kono H, Karmarkar D, Iwakura Y, Rock KL: Identification of the cellular sensor that stimulates the inflammatory response to sterile cell death. J Immunol 2010, 184(8):4470-4478. 55. Rock KL, Latz E, Ontiveros F, Kono H: The sterile inflammatory response. Annu Rev Immunol 2010, 28:321-342. 56. Enoksson M, Lyberg K, Moller-Westerberg C, Fallon PG, Nilsson G, Lunderius-Andersson C: Mast cells as sensors of cell injury through IL-33 recognition. J Immunol 2011, 186(4):2523-2528. 57. Gunawan BK, Kaplowitz N: Mechanisms of drug-induced liver disease. Clin Liver Dis 2007, 11(3):459-475, v. 58. Kaplowitz N: Acetaminophen hepatoxicity: what do we know, what don't we know, and what do we do next? Hepatology 2004, 40(1):23-26. 59. Hinson JA, Roberts DW, James LP: Mechanisms of acetaminophen-induced liver necrosis. Handb Exp Pharmacol 2010(196):369-405. 60. Martin-Murphy BV, Holt MP, Ju C: The role of damage associated molecular pattern molecules in acetaminophen-induced liver injury in mice. Toxicol Lett 2010, 192(3):387-394. 61. Ishida Y, Kondo T, Ohshima T, Fujiwara H, Iwakura Y, Mukaida N: A pivotal involvement of IFN-gamma in the pathogenesis of acetaminophen-induced acute liver injury. Faseb J 2002, 16(10):1227-1236. 62. Ishida Y, Kondo T, Tsuneyama K, Lu P, Takayasu T, Mukaida N: The pathogenic roles of tumor necrosis factor receptor p55 in acetaminophen-induced liver injury in mice. J Leukocyte Biol 2004, 75(1):59-67. 63. Williams CD, Farhood A, Jaeschke H: Role of caspase-1 and interleukin-1beta in acetaminophen-induced hepatic inflammation and liver injury. Toxicology and Applied Pharmacology 2010, 247(3):169-178. 64. Ishida Y, Kondo T, Kimura A, Tsuneyama K, Takayasu T, Mukaida N: Opposite roles of neutrophils and macrophages in the pathogenesis of acetaminophen-induced acute liver injury. Eur J Immunol 2006, 36(4):1028-1038. 65. Imaeda AB, Watanabe A, Sohail MA, Mahmood S, Mohamadnejad M, Sutterwala FS, Flavell RA, Mehal WZ: Acetaminophen-induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasome. J Clin Invest 2009, 119(2):305-314. 66. Francis H, Meininger CJ: A review of mast cells and liver disease: What have we learned? Dig Liver Dis 2010, 42(8):529-536. 67. Hokari R, Miura S, Fujimori H, Koseki S, Tsuzuki Y, Kimura H, Higuchi H, Serizawa H, Granger DN, Ishii H: Altered migration of gut-derived T lymphocytes after activation with concanavalin A. Am J Physiol 1999, 277(4 Pt 1):G763-772. 68. Torisu T, Nakaya M, Watanabe S, Hashimoto M, Yoshida H, Chinen T, Yoshida R, Okamoto F, Hanada T, Torisu K et al: Suppressor of cytokine signaling 1 protects mice against concanavalin A-induced hepatitis by inhibiting apoptosis. Hepatology 2008, 47(5):1644-1654. 69. Bonder CS, Ajuebor MN, Zbytnuik LD, Kubes P, Swain MG: Essential role for neutrophil recruitment to the liver in concanavalin A-induced hepatitis. J Immunol 2004, 172(1):45-53. 70. Nakamura K, Okada M, Yoneda M, Takamoto S, Nakade Y, Tamori K, Aso K, Makino I: Macrophage inflammatory protein-2 induced by TNF-alpha plays a pivotal role in concanavalin A-induced liver injury in mice. J Hepatol 2001, 35(2):217-224. 71. de Almeida Buranello PA, Moulin MR, Souza DA, Jamur MC, Roque-Barreira MC, Oliver C: The lectin ArtinM induces recruitment of rat mast cells from the bone marrow to the peritoneal cavity. PLoS One 2010, 5(3):e9776. 72. Galli SJ, Nakae S, Tsai M: Mast cells in the development of adaptive immune responses. Nat Immunol 2005, 6(2):135-142. 73. Jaeschke H: Mechanisms of Liver Injury. II. Mechanisms of neutrophil-induced liver cell injury during hepatic ischemia-reperfusion and other acute inflammatory conditions. Am J Physiol Gastrointest Liver Physiol 2006, 290(6):G1083-1088. 74. Schwabe RF, Brenner DA: Mechanisms of Liver Injury. I. TNF-alpha-induced liver injury: role of IKK, JNK, and ROS pathways. Am J Physiol Gastrointest Liver Physiol 2006, 290(4):G583-589. 75. ravi malaviya, teruo lkeda, elaine ross, soman n. abraham: <Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α.pdf>. Nature 1996, 381:77-79. 76. Carvalho M, Benjamim C, Santos F, Ferreira S, Cunha F: Effect of mast cells depletion on the failure of neutrophil migration during sepsis. Eur J Pharmacol 2005, 525(1-3):161-169. 77. Kneilling M, Mailhammer R, Hultner L, Schonberger T, Fuchs K, Schaller M, Bukala D, Massberg S, Sander CA, Braumuller H et al: Direct crosstalk between mast cell-TNF and TNFR1-expressing endothelia mediates local tissue inflammation. Blood 2009, 114(8):1696-1706. 78. Cynthia Ju, Timothy P. Reilly, Mohammed Bourdi, Michael F. Radonovich, John N. Brady, John W. George, Lance R. Pohl: Protective Role of Kupffer Cells in Acetaminophen-Induced Hepatic Injury in Mice. Chem Res Toxicol 2002, 15:1504-1513. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/31296 | - |
dc.description.abstract | 細胞壞死後會釋出的許多物質會引起體內的急性發炎反應,這種類型的發炎反應稱為無菌發炎反應,所引起的發炎反應其目的為移除細胞殘骸,避免造成周圍組織持續性的傷害,以及恢復組織內恆定。但是過多的白血球聚集到發炎反應部位卻反而對周圍正常細胞組織造成傷害,並引起許多相關疾病產生。而目前對於無菌發炎反應的機制並未能完全了解,在本研究中,我們使用三種無菌發炎反應模式來探討肥大細胞於發炎反應中的影響。 首先在壞死細胞引發的腹膜炎模式中,實驗結果顯示嗜中性球和單核球浸潤至腹膜中的數量在肥大細胞缺陷WBB6F1(KitW/KitW-v)小鼠中有明顯的減少,但若將由正常小鼠骨髓分化出之肥大細胞移植入此缺陷小鼠,則使嗜中性球和單核球的數量則有明顯的提升。 另外,在acetaminophen(AAP)和concanavalin A(ConA)所誘導的肝炎反應中,肥大細胞缺陷小鼠肝受損的程度以及發炎反應上都有明顯的下降,且在移植入正常之肥大細胞後,肝受損和發炎反應程度都較原本缺陷小鼠來的嚴重。在體外試驗中,壞死細胞可以活化由骨髓分化之肥大細胞,使之釋放細胞激素和及進行去顆粒化作用。 由本研究結果顯示,肥大細胞在細胞壞死所引起的發炎反應中佔有重要地位,因此如能對於肥大細胞的功能進行調節,也許可以應用於治療無菌性之發炎疾病上。 | zh_TW |
dc.description.abstract | Cell death in vivo releases intracellular components which induce an acute sterile inflammatory response. The physiological function of the sterile inflammatory response is to eliminate cell debris and restore tissue homeostasis; however the leukocytes accumulated in inflammed tissues may cause harm to healthy cells. Detailed mechanisms for causing the sterile inflammatory response are not fully elucidated. In this study, we used three sterile inflammatory mouse models to examine the role of mast cell in necrosis-induced inflammation. In the necrotic cell-induced peritonitis model, the number of neutrophils and monocytes infiltrated was remarkably reduced in mast cell deficient mice (W-/V-) compared to in the wild-type mice (WBB6F1), and the inflammatory response could be restored in in W-/V- mice receiving bone marrow-derived mast cells (BMMCs) (mast cell knockin mice). In addition, we investigated the effect of mast cell on hepatitis induced by acetaminophen (AAP) and concanavalin A (ConA). In both AAP and ConA models, mast cell deficient mice showed attenuated liver injury and neutrophil infiltration into liver, which were recovered in the mast cell knockin mice. We also found that necrotic cells could activate BMMCs to degranulate and release cytokines in vitro. Our results indicate that mast cells play a key role in regulating the inflammatory responses to cell death and therapeutic strategies targeting mast cells could be considering for treating diseases associated with sterile inflammation. | en |
dc.description.provenance | Made available in DSpace on 2021-06-13T02:41:16Z (GMT). No. of bitstreams: 1 ntu-100-R98b47113-1.pdf: 3370146 bytes, checksum: 6b74b46a74c9c945cd90b6f1a9dda96c (MD5) Previous issue date: 2011 | en |
dc.description.tableofcontents | Abstract I
中文摘要 III 目錄 IV 圖表目錄 VI 前言 1 1. 發炎反應概述 1 2. 發炎反應之細胞激素(cytokines)和細胞趨素(chemokines) 2 3. 白血球(leukocytes)之趨化作用 4 4. 肥大細胞(mast cells)與發炎反應 5 5. 細胞受損引起之無菌發炎反應 6 6. Acetaminophen(AAP)引起之肝損傷反應 8 7. Concanavalin A(ConA)誘導之肝炎反應 10 8. Neutrophils在肝損傷中扮演之角色 11 9. TNF-α在肝損傷中扮演之角色 12 10. 實驗基本概述 12 實驗目的 14 材料與方法 15 1. 實驗動物 15 2. 骨髓肥大細胞(BMMC)和mast cell Knockin小鼠模式 15 3. 製作EL4壞死細胞 15 4. 骨髓肥大細胞之細胞試驗和脫顆粒活性分析(Degranulation assay) 16 5. 以壞死細胞引起腹膜之發炎反應 17 6. 流式細胞儀 (Flow Cytometry) 分析 17 7. Acetaminophen及Concanavalin A 誘導之肝損傷發炎反應 18 8. 丙胺酸轉胺酶 (Alanine aminotransferase ; ALT)測定 18 9. 過氧化酶分析 (Myeloperoxidase assay ; MPO assay) 19 10. 細胞激素測定 (Cytokine measurement) 19 11. 統計分析 19 實驗結果 20 1. Mast cells為細胞受損引起無菌性發炎反應之感測細胞 20 2. Mast cells在受損細胞引起之腹膜炎模式中趨使白血球的浸潤作用 21 3. Mast cells促進AAP誘導的肝損傷與發炎反應 22 4. Mast cells參與ConA誘導的肝損傷與發炎反應 24 結果討論 26 結論 31 圖表 32 參考資料 50 Figure 1. Mast cells可被壞死細胞活化引起脫顆粒化作用 32 Figure 2. 壞死細胞可刺激mast cells釋放inflammatory cytokines 34 Figure 3. 以compound48/80去除mast cells可減少腹膜炎中腹腔內leukocytes比例 35 Figure 4. 以compound48/80去除mast cells可減少腹膜炎引起之leukocytes浸潤作用 36 Figure 5. 缺少mast cells可降低腹膜炎中腹腔內leukocytes比例 37 Figure 6. Mast cells可促進腹膜炎引起之leukocytes浸潤作用 38 Figure 7. Mast cells參與AAP引起之肝損傷反應 39 Figure 8. Mast cells促進AAP引起之肝損傷程度和neutrophils之浸潤作用 41 Figure 9.Mast cells促進AAP引起之肝臟發炎反應 42 Figure 10.Mast cells參與ConA引起之肝損傷反應 44 Figure 11. Mast cells促進ConA引起之肝損傷程度和neutrophils浸潤作用 46 Figure 12. Mast cells促進ConA引起之肝臟發炎反應 47 Figure 13. Mast cells於細胞受損引起之neutrophils inflammatory response推測作用路徑 49 | |
dc.language.iso | zh-TW | |
dc.title | 肥大細胞在細胞受損引起之無菌發炎反應中所扮演的角色 | zh_TW |
dc.title | Identification of the role of mast cell in sterile inflammation induced by necrotic cell | en |
dc.type | Thesis | |
dc.date.schoolyear | 99-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 許秉寧(Ping-Ning Hsu),陳念榮(Nien-Jung Chen) | |
dc.subject.keyword | 細胞受損,發炎反應,肥大細胞,乙醯氨酚,刀豆素A, | zh_TW |
dc.subject.keyword | Cell injury,inflammation,mast cells,acetaminophen,concanavalin A, | en |
dc.relation.page | 58 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2011-08-01 | |
dc.contributor.author-college | 生命科學院 | zh_TW |
dc.contributor.author-dept | 生化科技學系 | zh_TW |
顯示於系所單位: | 生化科技學系 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-100-1.pdf 目前未授權公開取用 | 3.29 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。